Pamala A. Pawloski, PharmD, outlines barriers to precision medicine adoption at AMCP Nexus 2026, calling for standardization ...

Experts at ASN Kidney Week say earlier detection, national CKD screening, and faster uptake are needed to bring new therapies ...

Elagolix 150 mg was noninferior to dienogest 2 mg for reducing moderate-to-severe endometriosis pain in a phase 3 trial of ...

Norah Terrault, MD, MPH, on why few diagnosed patients reach HCV cure and how primary care test-and-treat can close the gap.

Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was ...

An analysis of AccessHope case reviews found that experts recommended changes in more than 80% of cases. About half were ...

About half of patients with chronic hepatitis B or C also had MASLD, which tracked with worse fatigue and quality of life.

Patients with generalized myasthenia gravis who responded best to efgartigimod were not the ones with the biggest drop in ...

HHS enforcement discretion lets state pharmacies compound BPC-157 and other peptides amid rulemaking and legal challenges.

HHS does not intend to take enforcement action against pharmacies compounding BPC-157 and 5 other unapproved peptides if they ...

Sujith Ramachandran, PhD, associate director of Trinity Life Sciences, grouped access barriers into 3 buckets: upfront ...

A clinical-note analysis of more than 1000 patients found rising off-label BPC-157 use for pain and healing, with outcomes ...